Finding new antimicrobial peptides
Rising antimicrobial resistance is one of the most pressing global health crises of our time and could result in an estimated 10 million annual deaths globally by 2050. To prevent this, we urgently need to discover novel therapeutics. Antimicrobial peptides (AMPs), particularly bacteriocins, offer a promising alternative to traditional antibiotics because they have naturally evolved to target fundamental vulnerabilities in competing bacteria, from cell envelopes to essential intracellular machinery, making it difficult for pathogens to develop resistance.
The exponential growth of genomic and metagenomic sequencing has populated global databases with billions of natural amino acid sequences. This pool of natural data has already produced globally used bacteriocins like Nisin, alongside recent genome-mined breakthroughs such as Darobactin, Dynobactin, and Lariocidin.
Many, however, remain locked within the unannotated “dark matter” of protein databases, with their function uncharacterized because they aren’t similar to known proteins. For example, the world’s leading public resource of protein sequence and functional information, UniProt, holds millions of sequences with unknown functionality, transferred directly from genome sequencing projects.
To bridge this gap, Google developed ProtNLM (Protein Natural Language Model), a deep learning model trained to directly read the underlying evolutionary “grammar” of amino acid sequences. This allows the model to predict biological function directly from raw protein sequences, enriching millions of previously unnamed UniProt entries with high-confidence functional labels.




















